<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8649822" created="06/11/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8649822</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Identification of a <term id="T1" lex="human_LIM-Hox_gene" sem="DNA_family_or_group">human LIM-Hox gene</term>, <term id="T2" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term>, aberrantly expressed in <term id="T3" lex="chronic_myelogenous_leukaemia" sem="Other">chronic myelogenous leukaemia</term> and located on <term id="T4" lex="9q33-34.1" sem="DNA_domain_or_region">9q33-34.1</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T1"/>
<clue>Identification of a human LIM-Hox gene, hLH-2, aberrantly <clueType>expressed</clueType> <clueLoc>in chronic myelogenous leukaemia</clueLoc> and located on 9q33-34.1.</clue>
</event>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T2"/>
<clue>Identification of a <corefTheme>human LIM-Hox gene</corefTheme>, hLH-2, aberrantly <clueType>expressed</clueType> <clueLoc>in chronic myelogenous leukaemia</clueLoc> and located on 9q33-34.1.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We describe the isolation of <term id="T5" lex="human_LH-2" sem="Protein_molecule">human LH-2</term>, a <term id="T6" lex="putative_transcription_factor" sem="Protein_family_or_group">putative transcription factor</term> containing two <term id="T7" lex="cysteine-rich_region" sem="Protein_domain_or_region"><term id="T8" lex="cysteine" sem="Amino_acid_monomer">cysteine</term>-rich regions</term> (<term id="T9" lex="LIM_domain" sem="Protein_domain_or_region">LIM domains</term>) and a <term id="T10" lex="homeobox_(Hox)_DNA-binding_domain" sem="Protein_domain_or_region">homeobox (Hox) DNA-binding domain</term>.</sentence>
<sentence id="S3">High levels of <term id="T11" lex="hLH-2_expression" sem="Other"><term id="T12" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term> expression</term> were observed in all cases of <term id="T13" lex="chronic_myelogenous_leukaemia" sem="Other">chronic myelogenous leukaemia</term> (<term id="T14" lex="CML" sem="Other">CML</term>) tested, regardless of disease status.</sentence>
<event id="E5">
<type class="Gene_expression"/>
<theme idref="T12"/>
<clue>High levels of hLH-2 <clueType>expression</clueType> were observed in all cases of chronic myelogenous leukaemia (CML) tested, regardless of disease status.</clue>
</event>
<event Manner="High" id="E6">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<clue><clueType><clueManner>High levels</clueManner></clueType> <linkTheme>of</linkTheme> hLH-2 expression were <clueKT>observed</clueKT> <clueLoc>in</clueLoc> all cases of <clueLoc>chronic myelogenous leukaemia (CML)</clueLoc> tested, regardless of disease status.</clue>
</event>
<sentence id="S4"><term id="T15" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term> was mapped to <term id="T16" lex="chromosome_9Q33-34.1" sem="DNA_domain_or_region">chromosome 9Q33-34.1</term>, in the same region as the <term id="T17" lex="reciprocal_translocation" sem="Other">reciprocal translocation</term> that creates the <term id="A1" sem="DNA_substructure"><term id="T18" lex="BCR-ABL_chimera" sem="Protein_molecule">BCR-ABL chimera</term> of the <term id="T19" lex="Philadelphia_chromosome" sem="DNA_molecule">Philadelphia chromosome</term></term> (<term id="T20" lex="Ph&apos;" sem="DNA_molecule">Ph&apos;</term>), the hallmark of <term id="T21" lex="CML" sem="Other">CML</term>; <term id="T22" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term> was retained on the <term id="T23" lex="derivative_9_chromosome" sem="DNA_molecule">derivative 9 chromosome</term> and is therefore centromeric of <term id="T24" lex="c-ABL" sem="DNA_domain_or_region">c-ABL</term>.</sentence>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<cause idref="T17"/>
<clue>hLH-2 was mapped to <clueLoc>chromosome 9Q33-34.1</clueLoc>, in the same region as the reciprocal translocation that <clueType>creates</clueType> the BCR-ABL chimera of the Philadelphia chromosome (Ph&apos;), the hallmark of CML; hLH-2 was retained on the derivative 9 chromosome and is therefore centromeric of c-ABL.</clue>
</event>
<sentence id="S5">The proximity of <term id="T25" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term> to the breakpoint on <term id="T26" lex="chromosome_9" sem="DNA_molecule">chromosome 9</term> raises the possibility of <term id="T27" lex="cis-activation" sem="Other">cis-activation</term> by the <term id="T28" lex="t(9;22)(q34;q11)_translocation" sem="DNA_domain_or_region"><term id="A2" sem="DNA_domain_or_region">t(9;22)(q34;q11)</term> translocation</term>.</sentence>
<event KT="Other" id="E9">
<type class="DNA_recombination"/>
<theme idref="A2"/>
<clue>The proximity of hLH-2 to the breakpoint on chromosome 9 raises the possibility of cis-activation by the t(9;22)(q34;q11) <clueType>translocation</clueType>.</clue>
</event>
<event CL="L1" KT="Analysis" id="E10" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<cause idref="E9"/>
<clue>The proximity of hLH-2 to the breakpoint on chromosome 9 raises the <clueKT><clueCL>possibility</clueCL></clueKT> of <clueType>cis-activation</clueType> <linkCause>by</linkCause> the t(9;22)(q34;q11) translocation.</clue>
</event>
<sentence id="S6">In addition to finding <term id="T29" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term> expression in all cases of <term id="T30" lex="CML" sem="Other">CML</term>, expression was observed in <term id="T31" lex="lymphoid_malignancy" sem="Other">lymphoid malignancies</term> and <term id="T32" lex="myeloid_cell_line" sem="Cell_cultured">myeloid cell lines</term>, but not in primary cases of <term id="T33" lex="acute_myelogenous_leukaemia" sem="Other">acute myelogenous leukaemia</term>.</sentence>
<event id="E11">
<type class="Gene_expression"/>
<theme idref="T29"/>
<clue>In addition to finding hLH-2 <clueType>expression</clueType> in all cases of CML, expression was observed <clueLoc>in lymphoid malignancies</clueLoc> and myeloid cell lines, but not in primary cases of acute myelogenous leukaemia.</clue>
</event>
<event id="E14">
<type class="Gene_expression"/>
<theme idref="T29"/>
<clue>In addition to finding hLH-2 expression in all cases of CML, <clueType>expression</clueType> was <clueKT>observed</clueKT> <clueLoc>in</clueLoc> lymphoid malignancies and <clueLoc>myeloid cell lines</clueLoc>, but not in primary cases of acute myelogenous leukaemia.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E15">
<type class="Gene_expression"/>
<theme idref="T29"/>
<clue>In addition to finding hLH-2 expression in all cases of CML, <clueType>expression</clueType> was <clueKT>observed</clueKT> in lymphoid malignancies and myeloid cell lines, but <cluePolarity>not</cluePolarity> <clueLoc>in</clueLoc> primary cases of <clueLoc>acute myelogenous leukaemia.</clueLoc></clue>
</event>
<sentence id="S7">The role of <term id="T34" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term> in the development or progression of <term id="T35" lex="leukaemia" sem="Other">leukaemia</term> is not known.</sentence>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<clue>The role of hLH-2 in the <clueType>development</clueType> or progression <linkTheme>of</linkTheme> leukaemia is not known.</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<clue>The role of hLH-2 in the development or <clueType>progression</clueType> <linkTheme>of</linkTheme> leukaemia is not known.</clue>
</event>
<event KT="Investigation" id="E18" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E16"/>
<cause idref="T34"/>
<clue>The <clueType>role</clueType> of hLH-2 <linkTheme>in</linkTheme> the development or progression of leukaemia is <clueKT>not known</clueKT>.</clue>
</event>
<event KT="Investigation" id="E19" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E17"/>
<cause idref="T34"/>
<clue>The <clueType>role</clueType> of hLH-2 <linkTheme>in</linkTheme> the development or progression of leukaemia is <clueKT>not known</clueKT>.</clue>
</event>
<sentence id="S8">However, <term id="T36" lex="hLH-2" sem="DNA_domain_or_region">hLH-2</term> may prove useful as a marker of <term id="T37" lex="CML" sem="Other">CML</term> for monitoring <term id="T38" lex="residual_disease" sem="Other">residual disease</term>.</sentence>
<event CL="L1" KT="Analysis" id="E20">
<type class="Correlation"/>
<theme idref="T36"/>
<theme idref="T37"/>
<clue>However, hLH-2 <clueKT><clueCL>may</clueCL></clueKT> prove useful as a <clueType>marker</clueType> <linkTheme>of</linkTheme> CML for monitoring residual disease.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
